ArticleDiabetes, obesity & metabolism2022

Low-dose hydralazine reduces albuminuria and glomerulosclerosis in a mouse model of obesity-related chronic kidney disease.

Benjamin P Larkin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.